Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-022683
Filing Date
2021-02-16
Accepted
2021-02-16 06:51:58
Documents
1
Group Members
KAROLINSKA DEVELOPMENT ABKCIF CO-INVESTMENT FUND KB

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm215494d1_sc13ga.htm SC 13G/A 89483
  Complete submission text file 0001104659-21-022683.txt   90986
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 21632244
SIC: 2834 Pharmaceutical Preparations

Mailing Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65
Business Address TOMTEBODAVAGEN 23A SOLNA V7 SE 171 65 08-524 860 70
KDev Investments AB (Filed by) CIK: 0001789888 (see all company filings)

EIN.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13G/A